Medication info
Dapirile Tablet 4 mg (Glimepiride)

Dapirile Tablet 4 mg (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›4mg / 1 tablet
Manufacturer / importer
Hanin Pharmaceuticals Co., Ltd.
Appearance
Light blue oblong tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200704612 · Notified 2007.04.20 · Insurance code 657202180

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combining this medicine with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering medicines. When switching from another oral glucose-lowering medicine to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously administered. 4) Dose monitoring and adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Hanin Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

View approved original text

This medication is used to help manage blood sugar levels in patients with type 2 diabetes. It is administered as an adjunctive therapy when blood sugar control is difficult while following a diet and exercise regimen. It can also be used as monotherapy and may be combined with insulin when sufficient control is not achieved with oral hypoglycemics. Additionally, it may be used in combination with metformin when blood sugar control is difficult with sulfonylureas or metformin alone. Overall, this medication is used to effectively improve blood sugar control.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combining this medicine with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this medicine needed may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering medicines. When switching from another oral glucose-lowering medicine to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the medicine previously administered. 4) Dose monitoring and adjustment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication is not to be administered to patients with type 1 diabetes, diabetic ketoacidosis, or those in a comatose state. Patients allergic to this medication or sulfonylureas, as well as those with severe liver or kidney dysfunction, should also avoid its use. Pregnant or potentially pregnant women and nursing mothers should not take this medication. Insulin therapy is recommended for patients with severe infections, pre- and post-surgical conditions, or severe trauma. Patients with gastrointestinal disorders may have issues with drug absorption, increasing the risk of hypoglycemia. This medication contains lactose, so patients with specific genetic lactose metabolism disorders should not take it. During the first week of taking this medication, the risk of hypoglycemia is high, so blood sugar levels should be monitored frequently. Elderly patients, those with poor nutritional status or irregular eating habits, frequent alcohol consumers, and patients with impaired kidney or liver function should exercise additional caution. Additionally, when taking other medications, it's essential to inform the doctor or pharmacist as interactions may affect blood sugar control. If hypoglycemic symptoms occur, immediate appropriate measures should be taken, and severe symptoms may require hospitalization. Taking this medication can cause hypoglycemia, with symptoms including headache, intense hunger, nausea, fatigue, confusion, dizziness, drowsiness, and reduced consciousness. Transient visual disturbances, gastrointestinal symptoms, liver dysfunction, blood abnormalities, and allergic reactions may also occur; medical consultation is needed immediately for any of these symptoms. In particular, if allergic reactions such as hives or difficulty breathing occur, the medication should be discontinued immediately and medical attention sought. This medication must be taken regularly, and it is important to combine it with dietary and exercise therapy. If hypoglycemia occurs, consuming sugar or drinks containing sugar can alleviate symptoms; therefore, carrying a supply of sugar is advisable. Regular monitoring of blood glucose and urine tests during treatment is necessary to assess the drug's efficacy and side effects. Pregnant or nursing women should not take this medication, and if necessary, insulin therapy is a safer alternative. In case of overdose, severe hypoglycemia may occur, so inducing vomiting or seeking appropriate treatment at a hospital immediately is essential. If hypoglycemic coma occurs, glucose injection should rapidly restore blood sugar levels, and meticulous observation of blood sugar status should continue thereafter. The safety of this medication has not been established in children, and elderly patients may require dose adjustment due to decreased kidney function. Lastly, this medication should be stored out of the reach of children and kept in its original container.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorder, anxiety, aggression, decreased concentration, decreased agility or energy, depression, confusion, speech disorders, aphasia, visual impairment, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, hepatic dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disorder, hair loss, weight gain, dizziness, hepatic dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is advisable to maintain the storage temperature between 1 to 30 degrees Celsius. Proper storage will help retain the medication's efficacy and safety for an extended period.

Appearance and packaging

Appearance

Light blue oblong tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.